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Autosomal Dominant Central Areolar 
Choroidal Dystrophy Caused by a Mutation 
in Codon 142 in the Peripherin/RDS Gene
CAREL B. HOYNG, M.D., PETER HEUTINK, Ph.D., 
LEON TESTERS, ALFRED PINCKERS, M.D., 
AUGUST F. DEUTMAN, M.D., AND BEN A. OOSTRA, Ph D.
PURPOSE: Because several macular dystrophies 
are caused by mutations in the peripherin/RDS
gene, we examined autosomal dominant and spo­
radic cases of central areolar choroidal dystrophy 
for mutations in the peripherin/RDS gene.
METHODS: DNA sequence analysis of the periph­
erin/RDS gene was performed in four sporadic 
cases and in ten affected and nine unaffected 
individuals from seven families with autosomal 
dominant central areolar choroidal dystrophy.
RESULTS: An Arg-142-Trp mutation in the 
peripherin/RDS gene was found in ten affected 
family members in seven families. Among these, a 
69-year-old man with the Arg-142-Trp mutation, 
who was unaffected six years before blood sample 
analysis, showed a parafoveal area of chorioretinal 
atrophy. The 65-year-old sister of this family had 
the Arg-142-Trp mutation with no macular abnor­
malities, but she might still develop central areolar 
choroidal dystrophy at an older age. No mutation 
was found in the four sporadic cases.
• CONCLUSION: Autosomal dominant central 
areolar choroidal dystrophy, studied in seven fami-
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lies, is caused by an Arg-142-Trp mutation in the 
peripherin/RDS gene.
2
EN TR A L AREOLAR CHOROIDAL DYSTROPHY IS A  
hereditary disorder of the macula leading to a 
well-demarcated circumscribed area of atrophy 
of the pigment epithelium and choriocapillaris. 
Sorsby1 was the first to describe the genetic nature of 
central areolar choroidal dystrophy. In 1955, Sandvig
a family with dominant segregation of 
central areolar choroidal dystrophy, citing 13 cases 
spread over four generations. The classic signs and 
symptoms usually develop between the ages of 40 and 
60 years, leading to a central scotoma and visual 
impairment. Results of retinal functional analysis, by 
means of electroretinography, electro-oculography, 
subjective dark adaptation measurement, and color 
vision examination, are generally normal; however, in 
advanced cases, color vision is disturbed.1 The early 
stages of characterized by a fine, 
sometimes hardly detectable, mottling of the parafo­
veal pigment epithelium. In younger children whose 
parent has autosomal dominant central areolar cho­
roidal dystrophy, t hese changes are often not present.4
Various mutations in the retinal degeneration slow 
gene, which codes for peripherin/RDS, have been
.‘d in patients with retinitis pigmentosa, macu­
lar dystrophy, pattern dystrophy, fundus fl 
latus, and butterfly-shaped 
Wroblewski ; 
codon 172 ii
lystrophy,5'11 
reported mutations in
In those patients, the area of choroidal atrophy was 
larger than the area of atrophy found in central
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Fig. 1 (Hoyng and associates). Pedigrees of the seven families with autosomal dominant central areolar c 
dystrophy.
areolar choroidal dystrophy. Furthermore, loss of rod 
function was found in the dark-adapted rod electro- 
retinogram. The phenotypic resemblance between 
macular dystrophy and central areolar choroidal dys­
trophy and the finding that the peripherin/RDS gene 
is the only gene in which mutations have been shown 
to be responsible for macular dystrophies prompted 
us to investigate the involvement of the peripherin/ 
RDS gene in the onset of central areolar choroidal 
dystrophy.
PATIENTS AND METHODS
IN SEVEN FAMILIES W ITH  A U T O SO M A L  DOM INANTLY IN-
herited central areolar choroidal dystrophy (Fig. 1), 
we found 30 affected individuals with fundus changes
ranging from slight parafoveal depi
typical end stage, in which there is a well 
area of atrophy of pigment epithelium and c 
illaris in the posterior pole. From these f 
collected blood samples from ten affected i
s to the 
arcated
,\s. we
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Autosomal dominantly inherited
Gu 111-2 72 R.E./L.E.: normal «•Nt
Gu 111-4 70 R.E./L.E.: normal
1
WM)
Gu 111-5 69 R.E./L.E.: stage 3 +
Gu 111-6 68 R.E./L.E.: normal
Gu II1-7 36 37 R.E.: stage 3 
R.E.: stage 4
Gu 111-8 65 R.E./L.E.: normal 4*
Gu 111-10 63 R.E./L.E.: normal »*«*
Gu 111-14 58 R.E./L.E.: normal *****
Gu 111-17 53 47 R.E./L.E.: stage 2 4*
Ja 11-1 65 55 R.E./L.E.: stage 3 +
Si il-3 60 49 R.E./L.E.: stage 3 4-
Sta II-2 72 31 R.E./L.E.: stage 4 -f*
Sta li-4 64 R.E./L.E.: normal
Sta II-5 61 50 R.E./L.E.: stage 4 +
Te IV-10 30 25 R.E.: stage 3 
L.E.: stage 2
Ho II-2 60 54 R.E./L.E.: stage 3 +
Li lil-1 55 R.E./L.E.: normal 'At*M
Li HI-2 53 52 R.E./L.E.: stage 3
Li III-3 50 43 R.E.: stage 3 
L.E.: stage 4
m|*u
Sporadic
A 52 49 R.E./L.E.: stage 3 MWI
B 66 49 R.E./L.E.: stage 3
C 48 47 R.E./L.E.: stage 3 KDM
D 51 49 R.E./L.E.: stage 3 içauaa
*A plus sign indicates that the mutation was present; a minus sign, that it was absent.
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Fig. 2 (Hoyng and associates). Fluorescein angiogram of 
the left eye of an affected individual (Gu III-17). 
Hyperfluorescent areas are intermingled with hypofluo- 
rescent spots. The choriocapillaris is not yet affected 
(stage 2 central areolar choroidal dystrophy).
Fig. 3 (Hoyng and associates). Fluorescein angiogram of 
the right eye of an affected individual. Note the demar­
cated area of atrophy of the pigment epithelium and 
choriocapillaris and smaller choroidal vessels. The fovea 
is affected (stage 4 central areolar choroidal dystrophy).
parafoveal retinal pigment epithelial hypopigmenta­
tion; stage 2, retinal pigment epithelial hypopigmen­
tation involving the whole parafoveal area; stage 3, 
stage 2 and parafoveal atrophy of the choriocapillaris; 
and stage 4, stage 3 and choriocapillaris atrophy also 
affecting the fovea. The clinical and electrophysio- 
logic data of the family members and of the patients 
without a family history have been extensively de­
scribed.14 Examples of fluorescein angiograms of af­
fected individuals from whom blood samples were 
taken are shown in Figs. 2 and 3. This study was 
approved by the institutional review committee of 
Erasmus University, Rotterdam, The Netherlands.
Genomic DNA was isolated from peripheral blood, 
as described elsewhere.IS For mutation analysis, 25 ng 
of genomic DNA of all family members who were 
studied and the four patients with sporadic disease 
was subjected to 30 cycles of polymerase chain 
reaction. Part of exon 1 of the RDS 
amplified with the following primers: forward, 5'
GCCAAGTATGCCAGATGGAAG-3 '
from the middle of exon 1); reverse, 5'-ATAGCT-
CTGACCCCAGACTG-3 ' (derived from the 5'  end
of intron l ) .16 Polymerase chain reaction conditions
was
were as follows: initial aturation 5' at 95 C,
dénaturation for one minute at 95 C, annealing for 
one minute at 58 C, extension for one and a half 
minutes at 72 C, and a final extension for five minutes
at 72 C. After am ication,
re - -« ' were pun
polymerase chain 
on a Microcan 
column (Amicon, Inc., Beverly, Massachusetts). The 
same primers were end-labeled with gamma-’’P dATP
and were used for cycle sequencing according to the 
protocol provided by the Rethesda Research Lahora-
tories.
To screen for the presence of (he mutation in a 
population sample, an allele-specific oligohyhridiza-
hy using th e  follow ing prim* 
X X K 'iG A C -V , and mutat-ers: normal, 5'-GTAC
, 5 '-G T A C T A C T C ÏÜ C îA C A - V . I Iyhridi:atinn am
r conditions were described previously.1' In
individuals (5 0total, 200 ch romosomes from
men and 50 women) were tested.
I"*»'1 ‘ *'• *»»» B ru  :  n - r w m  »n-',« à t *  11 «*•■?** j r - ■ *S:
RESULTS
D N A  SE Q U E N C IN G  OF EXON I FOR FI IF TFN  INDFX IV\
tients of the seven families disclosed a cytosine-to
6 2 6 A merican Jo urnal  op O phthalmology lllNI I '(‘Mi
( 6 7 3 )
G
A G G  T  A C G T
5’
( 6 7 3 )
G 5Ï
A
C
A
C
A
G
G
G
-+ C/T
C
A
T
C
A
T
3' G
( 6 5 7 )
■A
■ y-1
•r-Îrdjj
y
w'&Mï:-
Ìj
A
c
A
C
A
G
G
G
C
C
A
■
C
A
G 3’
(6 5 7 ;
Affected Control
Homozygous control s 6 5 7 -  G TAC TAC CGG GAC ACA G -673 
Tyr Tyr Arg Asp Thr
Patient: 657 G  TAC TAC TGG GAC ACA G «67 3 
Tyr Tyr Trp Asp Thr
Fig (Hoy
analysis of exon pherin/RDS
left, sequence from a patient with central areolar choroi­
dal dystrophy and on the right, sequence from a homozy­
gous control sample. T h e  C-to-T base substitution is 
indicated by arrows. The numbers 673 and 657 repre­
sent povsitions of the bases in  the peripherin/RDS cDNA. 
Bottom, Nucleotide sequence and the corresponding
amino <
657 and
of the erin/RDS
in a homozygous control sample and a 
patient. Nucleotide change and corresponding amino 
acid substitution are indicated in bold.
. .. -.'i.i*
thymine change at position  664 of the peripherin/
gene.1'1 This base pair in an
amino acid substitution o f  a tryptophan residue by an
arginine residue at cod on  142 (Fig. 4). To test
this base pair change could be correlated 
with onset: o f the disease or should be considered to
be a polymorphism in th e  population, we
a n  t e o
mutation. In total, 2
general
ligohybridization test to detect this
Hroinosomes were tested from 
In none of these chromo-ton.
somes was the mutation detected. Subsequently, 
blood samples were collected from additional family 
members and four unrelated patients with a similar 
phenotype. The mutation was detected in all affected 
family members who were available (N =  10) and was 
not present in seven of nine family members without 
visual complaints.
Two individuals older than 50 years who had the 
mutation showed no sign of macular degeneration at 
the time of the initial diagnosis. In one of these 
patients (Gu III-5; male; age, 69 years), ophthalmos­
copy performed in 1988 disclosed no fundus abnor­
malities. Because of the traveling distance to our 
institute and because his poor physical condition did 
not permit him to visit us for réévaluation, we 
requested another ophthalmoscopic examination. He 
sent us Polaroid pictures taken with a nonmydriatic 
camera by his optician (Fig. 5). These pictures clearly 
showed an atrophic lesion of the posterior pole with 
sparing of the fovea, confirming our findings on the 
DNA level. The second individual (Gu III-8; female; 
age, 65 years) with the mutation agreed to have 
a reexamination. Visual acuity was 20/20 in both 
eyes. Ophthalmoscopy and fluorescein angiography 
showed no abnormalities in the posterior pole.
In the four sporadic cases without family history of 
central areolar choroidal dystrophy, no mutations 
were observed in the complete screening of the 
coding region of the peripherin/RDS gene (data not 
shown).
DISCUSSION
RETINITIS PIGMENTOSA, A S  WELL A S S E V E R A L  DYSTRO -
phies of the macula, has been associated with muta­
tions of the peripherin/RDS gene. A  Pro-216-Ser
mutation was demonstrated in a family with retinitis 
pigmentosa and pattern dystrophy,8 whereas a Pro- 
21 0-Arg mutation was found in a family with both 
peripheral and macular degeneration.15 A  3-base pair 
deletion in codon 153 or 154 has been described in a
family with phenotypes of retinitis pigmentosa, fun­
dus flavimaculatus, and pattern dystrophy.y Butterfly 
dystrophy has been associated with Gly-167-Asp, a
2-base pair deletion affecting codons 299 and 300, 
and a 4-base pair insertion at codon 140.7,10,11 An  
Arg-172-Trp mutation was detected in two families,
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Fig. 5 (Hoyng and associates). After the Arg-142-Trp
mutation was found in blood sample analysis, the picture
of the right eye of a 69-year-old individual (Gu III-5) 
established a demarcated area of atrophy of pigment 
epithelium and choriocapillaris adjacent to the fovea 
(stage 3 central areolar choroidal dystrophy). Six years 
before the blood sample analysis, no abnormalities were 
found in ophthalmoscopic examination.
and an Arg-172-Gln mutation was found in one 
family with macular dystrophy.'1,12
The phenotype of central areolar choroidal dystro-
RDS gene. This base pair change leads to a substitu­
tion from arginine to tryptophan (Arg-142-Trp). 
Similar to most other mutations that have been 
reported so far for other macular dystrophies, the 
mutation in central areolar choroidal dystrophy is 
located in the second interdiskal loop of the periph- 
erin molecule.18 Three other mutations are located 
in the transmembrane segments 1, 3, and 4.18 The 
function of the peripherin molecule is unknown, but 
it has been suggested that it functions as an adhesion 
molecule, stabilizing outer
or heterophilic interactions 
interdiskal space. The second intradiskal loop of the 
peripherin protein is located extracellularly and prob­
ably is involved in these interactions.
In one 65-year-old patient (Gu III-8), the Arg-142-
Trp mutation was found, although no macular chang­
es were observed on fluorescein angiography. Howev­
er, as in her brother (Gu HI-5), in whom the atrophy 
became manifest between the ages of 63 and 69 years, 
central areolar choroidal dystrophy could still develop 
at an older age.
In the four sporadic cases, no mutation was found 
in the regulatory region of the peripherin/RDS gene. 
Either the phenotype was caused by a mutation in the 
noncoding region of the peripherin/RDS gene or by a 
mutation in a different gene. In these families we 
found no other affected individuals. Therefore, it was
not p to mine the •'•‘ase in
phy in our • I t clearly from those of
fundus flavimaculatus,9 pattern dystrophy,8,9 and but­
terfly dystrophy.7,10,11 No typical flecks or patternlike 
hyperpigmentations were observed in our patients. 
The phenotype of macular 
does show to central areolar choroidal 
dystrophy. Severe visual loss in siblings from families
\  4with macular dystrophy developed before the 
40 years. Although atrophy of the retinal pigment 
epithelium was demonstrated early in their lives, in 
our family members, disabling decrease of vision 
generally developed in their seventh decade, when
these patients is linked to the peripherin/RDS 
In conclusion, we found an Arg-142-Trp mutation 
in seven families with autosomal dominant central 
areolar choroidal dystrophy. Although from our earli­
er studies penetrance was estimated to be 100% above 
the age of 50 years, we found one individual who 
carried the mutation but had not developed any signs 
of central areolar choroidal dystrophy at: the age of 65 
years. Her affected brother developed signs of cent ral
ar choroidal dystrophy between the ages of 
and 69 years.
■ji*« wmmaM»igfigpn
the atrophy the fovea. Furthermore, the
atrophic macular lesions in our patients were smaller 
and not connected to the optic disk.
In all the 
blood samples were
family from whom
, a change from C to T
was found at position 664, resulting in a change of
codon 142 from CGG to TG G  in the peripherin/
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